XSHE
301116
, Last price
Name
JiangSu YiKe Food Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Yike Food Group Co.,Ltd specializes in the slaughter and preparation of poultry, serving both the domestic Chinese market and international clientele. The company boasts an extensive and varied product line. This encompasses a broad selection of duck items, including diverse duck blood preparations (such as braised, frozen, hot pot, and duck blood tofu) and numerous duck parts like tongues, legs, feet, gizzards, necks, livers, and whole or half ducks, along with duck jerky, duck intestines, and assorted duck skewers. Their chicken offerings are equally comprehensive, featuring breasts, feet, boneless options, wing roots, and various chicken chops (e.g., star, whirlwind, snowflake, Sichuan), grilled wings, chicken skin skewers, and cumin drumsticks. Beyond poultry, their product assortment also extends to complementary food items. These include different tofu products (dried, skin, yuba), vegetables and fungi like kelp knots, enoki mushrooms, marinated shiitake, lotus root slices, and seaweed strips. Their selection is further enhanced by an array of other skewered items, such as Australian skewers, beef skewers, and grilled sausage slices. In addition to its core food processing operations, Jiangsu Yike Food Group Co.,Ltd is actively involved in upstream poultry industry activities. This includes the manufacturing and distribution of animal feed and poultry seedlings, alongside commodity hatching and the breeding of both poultry and specific poultry breeds. Established in 2004, the firm maintains its corporate headquarters in Suqian, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||